Sage Journals: Discover world-class research

Abstract

The hybrid closed-loop insulin delivery system, a form of “artificial pancreas,” is composed of an insulin pump, a standardized algorithm, and a continuous glucose monitor. The system streamlines insulin delivery by connecting continuous glucose monitor data with an insulin pump and an algorithm to drive basal insulin delivery. The hybrid closed-loop insulin delivery system, approved by the Food and Drug Administration in 2016 for children older than 7 years, is a major improvement in the management of type 1 diabetes. The purpose of this article is to educate school nurses about the components of the hybrid closed-loop insulin delivery system, the relevance to care, and the future direction of blood glucose management.

Keywords

artificial pancreas hybrid closed-loop insulin delivery diabetes school nurse children

Get full access to this article

View all access options for this article.

References

American Diabetes Association. (2018b). 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018. Diabetes Care, 41(Suppl 1), S55-S64. doi:10.2337/dc18-S006

El-Khatib

F. H.

Balliro

Hillard

M. A.

Magyar

K. L.

Ekhlaspour

Sinha

. . . Russell

S. J.

(2016). Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: A multicenter randomized crossover trial. Lancet, 389, 369-380. doi:10.1016/S0140-6736(16)32567-3

Kropff

Choudhary

Neupane

Barnard

Bain

S. C.

Kapitza

. . . DeVries

J. H.

(2017). Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: A 180-Day, prospective, multicenter, pivotal trial. Diabetes Care, 40, 63-68. doi:10.2337/dc16-1525

Medtronic. (2016). MiniMed 670G system school nurse guide. Retrieved from http://www.medtronicdiabetes.com/important-safety-information#minimed-670gz

Medtronic. (2018). The MiniMed 670G insulin pump system. Retrieved from http://professional.medtronicdiabetes.com/minimed-670g-insulin-pump-system

National Institute of Diabetes and Digestive and Kidney Disease. (2018). Helping the student with diabetes succeed: A guide for school personnel. Retrieved from https://www.niddk.nih.gov/health-information/communication-programs/ndep/health-professionals/helping-student-diabetes-succeed-guide-school-personnel

Ramkissoon

Herrero

Bondia

Vehi

(2018). Unannounced meals in the artificial pancreas: Detection using continuous glucose monitoring. Sensors, 18(3), E884. doi:10.3390/s18030884

Treviss

Simpson

Wood

(2016). Artificial pancreas device systems for the closed-loop control of type 1 diabetes: What systems are in development? Journal of Diabetes Science and Technology, 10, 714-723. doi:10.1177/1932296815617968

Turksoy

Frantz

Quinn

Dumin

Kilkus

Hibner

. . . Littlejohn

(2017). Automated insulin delivery: The light at the end of the tunnel. Journal of Pediatrics, 186, 17-28.e9. doi:10.1016/j.jpeds.2017.02.055

10.

U.S. Food and Drug Administration. (2016). FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions. Retrieved from https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm534056.htm

11.

U.S. Food and Drug Administration. (2017). FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration. Retrieved from https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm577890.htm

12.

U.S. Food and Drug Administration. (2018a). June 2018 PMA approval list. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/default.htm

13.

U.S. Food and Drug Administration. (2018b). MiniMed 670G system—P160017/S017. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm600603.html

14.

U.S. Food and Drug Administration. (2018c). FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes. Retrieved from https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm611454.htm

The Artificial Pancreas: What School Nurses Need to Know

Abstract

Keywords

Get full access to this article

References